alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer

Term ID

CHEBI:27718

Synonyms

Type IIIH glycolipid

Definition

A glycooctaosylceramide in which the sugar component is a linear heptasaccharide comprised of fucose, galactose, N-acetylgalactosamine, glucose and N-acetylglucosamine residues, branched with an extra L-fucosyl residue at one of the central galactose residues within the chain.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: fucosyl oligoglycosylceramide glycooctaosylceramide

fucosyl oligoglycosylceramide glycooctaosylceramide Show first 5 Terms
has_role: mouse metabolite

mouse metabolite Show first 5 Terms

Phenotype

Phenotype resulting from alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer

Phenotype where environments contain alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer

Phenotype modified by environments containing alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer

Human Disease Model